Jose Arrascue
Nephrology · Atlantis, FLNPI 1063403889
Payments from drug & device makers
Across 136 payments — averaging $285.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Outset Medical Inc$30K
- Otsuka America Pharmaceutical, Inc.$8K
- AstraZeneca$591
- Akebia Therapeutics Inc$245
- GSK$140
- Vifor Pharma, Inc.$132
- plus $568 from 14 others
What the payments were for
- Consulting fees$5,60014%
- Speaking & faculty fees$25,47566%
- Travel & lodging$4,44911%
- Food & beverage$3,2848%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Outset Medical Inc | 36 | $29,529 |
| Otsuka America Pharmaceutical, Inc. | 29 | $7,608 |
| AstraZeneca(2 entities) | 29 | $591 |
| Akebia Therapeutics Inc | 10 | $245 |
| GSK | 2 | $140 |
| Vifor Pharma, Inc. | 7 | $132 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| OPKO Pharmaceuticals, LLC | 4 | $82 |
| Mallinckrodt Enterprises LLC | 3 | $61 |
| Amgen(2 entities) | 3 | $57 |
| Nxstage Medical, Inc. | 1 | $56 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $36 |
| Nuwellis, Inc. | 1 | $32 |
| Bayer | 2 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,814 in reported general payments places this provider in the 80th percentile of 756 nephrology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $15,053 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Atlantis
- David HalpertAtlantis$4.2M
- Thomas MarburyOrlando$41.1M
- Julio VijilHollywood$16.1M
- Steven ZeigHollywood$14.3M
- Oscar GalvezMiami$14.2M
- Jesus NavarroTampa$13.3M
- Arvind MadanOrlando$9.7M
- Wayne KotzkerFort Lauderdale$3.4M
- Edouard MartinLauderdale Lakes$2.7M
- Jorge PosadaCoral Gables$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.